Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-01-16

FDA Approved: TAPENTADOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Tapentadol hydrochloride (generic) submitted by Hikma Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tapentadol (Tapentadol hydrochloride)

Snippet

SUPPL AP for TAPENTADOL (TAPENTADOL HYDROCHLORIDE)